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ABSTRACT 
FORMULATION AND CHARACTERIZATION OF BIFONAZOLE MULTIPLE EMULSION 
Superficial fungal infections of the skin (dermatomycoses) are among the most 
common diseases presented in our daily practice throughout the world. These 
infections are contagious diseases caused by either a human (anthropophilic) or animal 
(zoophilic) species of dermatophyte fungi. Nowadays, antifungal treatments are 
becoming even more important due to the increase of dermatomycoses prevalence. 
Nonetheless, antifungal clinical feasibility is limited by imidazole antifungal drug 
properties. As a consequence, new formulations, such as multiple emulsions, are being 
investigated in order to improve the antifungal drug bioavailability.  
The aim of the present study is the formulation and characterization of different 
multiple emulsions which contain Bifonazole as antifungal drug. The last of these is 
performed straightaway after the preparation of the multiple emulsions and during 
the storage period.  
To conclude the study, a comparison among the multiple emulsions formulationsis 
carried out and significant discrepancies analysed. As a result, the selection of the 
most suitable formulation for Bifonazole stability might be purposed.  
FORMULACIÓ I CARACTERITZACIÓ D’EMULSIONS MÚLTIPLES DE BIFONAZOL 
Les infeccions fúngiques superficials de la pell (dermatomicosis) es troben entre les 
malalties més comuns actualment arreu del món. Aquestes infeccions són malalties 
contagioses causades tant per l’home (antropofílic) com per animals (zoofílic). 
Actualment, els tractaments antifúngics estan adquirint molta rellevància degut a 
l’augment de la prevalença de les dermatomicosis. Tanmateix, l’eficàcia clínica dels 
fàrmacs antifúngics està limitada per les propietats dels seus principis actius. Com a 
conseqüència, noves formulacions, com les emulsions múltiples, estan sent 
investigades per tal de millorar la biodisponibilitat dels principis actius antifúngics. 
L’objectiu principal d’aquest estudi és la formulació i caracterització de diferents 
emulsions múltiples que contenen Bifonazol com a principi actiu antifúngic. Aquesta 
caracterització es dur a terme immediatament després de la preparació de les 
emulsions múltiples i durant el període d’emmagatzemament.  
Per concloure aquest estudi, es realitza una comparació entre les diferents emulsions 
múltiples i s’analitzen les discrepàncies significatives. Com a resultat, es proposa quina 
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és la formulació d’emulsió múltiple més estable utilitzant el Bifonazol com a principi 
actiu. 
FORMULACIÓN Y CARACTERIZACIÓN DE EMULSIONES MÚLTIPLES DE BIFONAZOL 
Las infecciones fúngicas superficiales de la piel (dermatomicosis) se encuentran entre 
las enfermedades más comunes actualmente en todo el mundo. Estas infecciones son 
enfermedades contagiosas causadas tanto por el ser humano (antropofílico) como por 
animales (zoofílico). Actualmente, los tratamientos antifúngicos están adquiriendo 
mucha relevancia debido al aumento de la prevalencia de las dermatomicosis. No 
obstante, la eficacia clínica de los fármacos antifúngicos está limitada por las 
propiedades de sus principios activos. Como consecuencia, nuevas formulaciones, 
como las emulsiones múltiples, están siendo investigadas con el fin de mejorar la 
biodisponibilidad de los principios activos antifúngicos. 
El objetivo principal de este estudio es la formulación y caracterización de diferentes 
emulsiones múltiples que contienen Bifonazol como principio activo antifúngico. Esta 
caracterización se lleva a cabo inmediatamente después de la preparación de las 
emulsiones múltiples y durante el periodo de almacenamiento. 
A modo de conclusión, se realiza una comparación entre las distintas emulsiones 
múltiples y se analizan las discrepancias significativas. Como resultado, se propone qué 
formulación de emulsión múltiple es más estable utilizando el Bifonazol como principio 
activo. 
  
7 
 
INTEGRATING EDUCATIONAL FIELDS  
The present study integrates contributions from different educational fields. During its 
development knowledge of Pharmaceutical Technology, Biopharmacy and 
Pharmacokinetics and Legislation areas have been integrated. 
- Pharmaceutical Technology: It is the main field of the study. The role of the 
Pharmaceutical Technology area of knowledge and skills were focused on the 
development of the multiple emulsions and its further characterization.  
- Biopharmacy and Pharmacokinetics: To broad the knowledge about multiple 
emulsions beyond stability, is crucial to determinate the Bifonazole release 
properties and therefore, its pharmacokinetics characteristics.  
- Legislation: The legislation area is basic to establish the normative framework. 
ICH guidelines have been followed during all the multiple emulsions 
development.  
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1. INTRODUCTION 
1.1. SIMPLE EMULSIONS CONSIDERATIONS 
A simple emulsion, also called just emulsion, consists of two immiscible liquids (usually 
oil and water), with one being dispersed as small spherical droplets inside the other. 
The substance that makes up the droplets in an emulsion is referred to as the 
dispersed, discontinuous or internal phase, whereas the one that surrounds is called 
the continuous or external phase (1). 
Emulsions can be classified according to the relative spatial distribution of the oil and 
aqueous phase:  
a) Oil-in-water emulsion (O/W): Oil droplets are dispersed in an aqueous phase 
(Figure 1.1 a) 
b) Water-in-oil emulsion (W/O): Water droplets are dispersed in an oil phase 
(Figure 1.1 b) 
 
Figure 1: Oil-in-water emulsion (a) and water-in-oil emulsion (b) (2) 
1.2. MULTIPLE EMULSIONS 
Multiple emulsions are complex systems which many authors have called “emulsions 
of emulsions” (3,4). In 1925 Seifriz described multiple emulsions as the phase inversion 
of a simple emulsion(5).Multiple emulsions are formed from a dispersion of droplets 
which themselves contain smaller droplets of a liquid identical or similar to the 
external continuous phase. In multiple W/O/W emulsions, the internal and external 
phases are separated by an oil layer and require at least two surfactants for their 
common formation. The one with low HLB is used to form the primary w/o emulsion 
while the one with the high HLB is used to achieve secondary emulsification. The key 
factors affecting the formation of multiple emulsions are the chemical nature of 
various components, the concentration of the surfactants used in both steps of 
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emulsification, the volume fraction of the primary emulsion in the whole multiple 
emulsion and the mixing conditions (6,7).  
The two major types are water-in-oil-in-water (w/o/w) and oil-in-water-in-oil (o/w/o) 
emulsions: 
a) Water-in-oil-in-water emulsion: Small water droplets are dispersed in oil 
(water-oil primary emulsion (W/O)), and this primary emulsion is dispersed as 
large droplets inside an aqueous continuous phase (Figure 2). 
b) Oil-in-water-in-oil emulsions: Small oil droplets are dispersed in water (oil-
water primary emulsion (O/W)), and this primary emulsion is dispersed as large 
droplets in an oil continuous phase (Figure 2). 
 
Figure 2: Schematic drawing of various types of emulsions (8) 
Both types of double emulsions are often prepared through a two-step emulsification 
process. Firstly, the primary emulsion is prepared, followed by a re-emulsification in an 
oil solution or an aqueous solution in order to obtain the double emulsion. 
Double emulsions have shown significant promises in many technological fields and for 
many applications because of their special structure. They highly suited in 
pharmaceutical, cosmetics and food industries (9,10). However, they only represent a 
little rate in the market (especially cosmetics products) due to the inherent instability 
of the preparation.  
Their potential pharmaceutical applications include uses such as adjutant vaccines, 
prolonged and sustained drugs delivery systems or sorbent reservoirs of drug overdose 
treatments among others.  
1.3. BIFONAZOLE PROPERTIES 
Bifonazole (C22H18N2) is a substituted imidazole antifungal agent structurally related to 
other drugs in this group as clotrimazole, econazole, miconazole, oxiconazole and 
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sulconazole. It is a white powder highly lipophilic with a very short half-life (1-2h) and 
is minimally absorbed following dermal application (0.6% of an applied dose) (11). 
 
Figure 3: Bifonazole molecular structure (12) 
It has demonstrated a broad spectrum of antifungal activity inhibiting the growth of 
moulds, yeasts, dermatophytes, dimorphic fungi and some Gram-positive 
bacteria(13).Bifonazole works by inhibiting ergosterol production, which is an essential 
component of fungal cell membranes. It destabilizes the fungal cytochrome P450 51 
enzyme and its inhibition leads to cell lysis (14). 
This antifungal drug is used for the treatment of superficial fungal skin infections such 
as dermatophytoses, cutaneous candidiasis and pityriasis versicolor (13).Bifonazole can 
be found in various solid dosage forms as cream, gel, solution or powders. However, all 
types of dosage forms are effective in formulations of Bifonazole 1% applied once 
daily. 
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2. OBJECTIVES 
The aim of this academic work is to formulate different multiple emulsions for topical 
application containing Bifonazole as API. They have been developed according to the 
experience of the research group at Technology Department. 
In order to achieve this objective, several specific goals have been proposed: 
1. Formulation and preparation of different water-in-oil-in-water emulsions 
containing Bifonazole. 
2. Characterization of these double emulsions by analysing morphology, droplet 
size, pH and conductivity values, viscosity, thermal stability and drug content.  
3. Improve double emulsions stability by: 
a. Modifying the nature of the oil phase. 
b. Performing Ultra-Turrax method. 
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3. MATERIALS AND METHODS 
3.1. MATERIALS 
3.1.1. API and excipients 
The multiple emulsion components are of significant importance to ensure the stability 
and release properties desired. 
The excipients used for the multiple emulsion formulation are detailed below (Table 
1).The water used in all experiments was obtained from the MilliQ® Plus System 
located at SDM (Servei de Desenvolupament del Medicament) at the Pharmacy Faculty 
of Universitat de Barcelona.  
 
  Name Supplier Lot Expiry date 
P
R
IM
A
R
Y
 E
M
U
LS
IO
N
 
O
il 
P
h
as
e
 
Bifonazole Acofarma 141824 30.11.2020 
Abil® EM 90 
(cetyldimethiconecopolyol) 
Evonik 
Industries 
ES14700950 14.07.2016 
Span® 60 (sorbitan stearate) Fagron L14060137 04.2016 
Cetyl palmitate Acofarma 140774 18.11.2016 
Isopropyl Myristateoil (IM)* Acofarma 140952-N-1 18.04.2020 
Jojoba oil (YB)* Acofarma 141311-N-1 01.04.2016 
Sweet almonds oil (SA)* Acofarma 151389-P-1 01.07.2017 
In
te
rn
al
 
aq
u
eo
u
s 
p
h
as
e
 Sodium chloride Acofarma 130177 31.12.2016 
Purified water SDM --- --- 
G
EL
 (
EX
TE
R
N
A
L 
A
Q
U
EO
U
S 
P
H
A
SE
) 
Tego® Betain F 
(cocamidopropil betaine) 
Evonik 
Industries 
ES614907754 20.10.2016 
Tego® carbomer 341 ER 
(carbomer) 
Evonik 
Industries 
ES974DA010 05.2016 
Purified water SDM --- --- 
Table 1: Excipients' information 
  
                                                          
*
 Only one type of oil was used in each formulation 
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3.1.2. Instrumental 
Name Model Supplier 
Mettler Balance PJ 300 Delta Range Mettler Toledo, S.A.E, Spain 
Analytical balance Kern®  ALJ 220-4 Karn&Sohn, GmH, Germany 
Thermostatic bath Selecta Selecta Precisterm S-138 JP Selecta, S.A., Spain 
Mechanical shaker Schott Schott RM 144D Schott Ibérica, S.A., Spain 
Ultra-Turrax J&K  TP 18/10 55 
Janke& Kunkel. IKA, GmbH, 
Germany  
Multi position magnetic 
stirrer + heating plate 
Heidolph 50301. MR-1  
Heidolph Instruments GmbH 
& Co, Germany 
pH-MeterCrison CrisonmicropH 2000 Crison Instruments, S.A., Spain 
ConductimeterCrison GLP 32 Crison Instruments, S.A., Spain 
Optic Microscope Leica DM 1000 LED 
Leica Microsystems Ltd., 
Switzeland 
Rotational Rheometer 
Thermo Scientific 
HAAKE RheoStress 1 
Thermo Fischer Scientific, 
GmbH, Germany 
Turbiscan Lab®  Formulaction Formulaction, L’Union, France 
Mastersizer S Malvern 
Malvern Instruments Ltd., 
Malvern, UK 
30ºC, 40ºC and 50ºC ovens Heraeus B5042 E Heraeus, S.A., Spain 
Ultrasonic bath Selecta Selecta 3000513  JP Selecta, S.A., Spain 
Centrifuge Selecta Centronic BLT JP Selecta, S.A., Spain 
Spectrophotometer 
ThermoSpectronic 
Helios Beta 
Thermo Fischer Scientific, 
GmbH, Germany 
Table 2: Instrumentals information 
3.2. METHODS 
3.2.1. Water-in-oil-in-water (W/O/W) emulsions preparation 
The most used method is to prepare a multiple emulsion in a two-step emulsification 
process (15). Both procedures consist in the preparation of a primary emulsion and its 
further emulsification with the external water phase (gel). In both emulsions a 
combination of surfactants is used to ensure the long-term stability of double emulsion 
(3,16). Therefore, multiple emulsions contain, at least, two surfactants: 
a. Lipophilic surfactants: Abil® EM 90 and Span® 60 are used as low hydrophilic-
lipophilic balance (HLB) surfactants to stabilize the interface of primary 
emulsions (W/O emulsions). 
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b. Hydrophilic surfactant: Tego® Betain F is used as high HLB surfactant in order 
to stabilize the external interface in W/O/W emulsions. 
 
Figure 4: Two-step emulsification process (17) 
Different multiple emulsion formulations were prepared using three different oils in its 
oil phase in order to compare the stability of Bifonazole. All multiple emulsions coding 
and composition is described in the table below (Table 3). 
 
Name 
Amount (%) 
JMIM01B JMIM01BT JMYB01BT JMSA01B JMSA01BT 
   Oil phase 
Bifonazole 1,00 1,00 1,00 1,00 1,00 
Abil® EM 90 1,50 1,50 1,50 1,50 1,50 
Span® 60 2,00 2,00 2,00 2,00 2,00 
Isopropyl Myristate Oil 11,00 11,00 -- -- -- 
Jojoba Oil -- -- 11,00 -- -- 
Sweet Almonds Oil -- -- -- 11,00 11,00 
Cetyl palmitate 1,00 1,00 1,00 1,00 1,00 
   Internal Aqueous Phase 
Sodium Chloride 0,25 0,25 0,25 0,25 0,25 
Purified water 32,25 32,25 32,25 32,25 32,25 
   Gel (External Aqueous Phase) 
Tego® Betain F 0,70 0,70 0,70 0,70 0,70 
Tego® Carbomer 341 ER 0,20 0,20 0,20 0,20 0,20 
Purified water 49,00 49,00 49,00 49,00 49,00 
Table3: Multiple emulsions composition 
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With regard to the preparation of the primary emulsion, first it was necessary to 
prepare separately the water and oil phases. Water phase was prepared by dissolving 
0,25g of NaCl in 32,35g of purified water. The oil phase was prepared by dissolving 1g 
of Bifonazole, 1,5 g of Abil® EM 90,2g of Span®60 and 1g of Cetyl palmitate in different 
oils depending on the formulation prepared. The oils used were Isopropyl Myristate 
(IM), Jojoba Oil (YB) and Sweet Almonds Oil (SA). In all cases 11g of oil was used.  
Then, the two respective beakers with the oil and the water phase were stirred and 
heated until 70ºC (approximately during 8 minutes). 
Once both phases are prepared, the water phase was poured into the oil phase under 
constant stirring of 300-400 rpm during 5 minutes. Thus, the primary emulsion (W/O) 
is obtained. 
To prepare the external water phase (gel) which would be emulsified with the primary 
emulsion, 0,2g of Tego® Carbomer was dispersed in 49g of purified water containing 
0,7g of Tego® Betain F. The gel was acquired by 24 hours of resting at room 
temperature. The following day, the dispersion was neutralized with a NaOH 10% 
solution to adjust the gel pH up to 6,5-7. 
Finally, the water-in-oil-in-water emulsion was prepared by pouring the primary 
emulsion (W/O) into the external water phase (gel) under mixing using mechanical 
stirring during 15 minutes. 
The multiple emulsions obtained were coded in function of its oil phase composition 
and considering if it was used the Ultra-Turrax method (Table 4). 
 
Sample 
Code 
Oil phase 
composition 
Ultra-Turrax 
Method 
JMIM01B Isopropyl Myristate oil No 
JMIM01BT Isopropyl Myristate oil Yes 
JMYB01BT Jojoba oil Yes 
JMSA01B Sweet almonds oil No 
JMSA01BT Sweet almonds oil Yes 
Table 4: Samples codes of W/O/W prepared 
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3.2.2. Characterization of the water-in-oil-in-water emulsions 
Once the W/O/W emulsion has been prepared, some tests have to be done in order to 
characterize it. It is crucial to determine the properties such as viscosity and also to 
examine its appearance to be able to compare different multiple emulsion samples. 
All the measurements should be performed right after the preparation of the W/O/W 
emulsion, as well as after a certain period of time. The characterization of the sample 
includes visual appearance (organoleptic characteristics), microscopic observations, pH 
and conductivity determination, particle size analysis, stability studies and rheological 
measurements.  
3.2.2.1. Microscopic analysis 
Observations using a Leica Microsystems DM 1000 LED model were performed to 
observe the water-in-oil-in-water emulsions. 
Firstly, multiple emulsion was diluted ten times with deionized water. Afterwards, 
using a pipette, one droplet of the diluted emulsion was brought on a 76 x 26 mm 
(Menzel-Glaser) microscope slide and it was covered with a 15 x 15 mm microscope 
slide cover (Menzel-Glaser). Finally, the sample was observed through microscope using 
40x/0.25 Ph1 objective lens. Pictures were made using the Leica Microsystems EC 
model microscope camera. 
3.2.2.2. PH determination 
Straightaway the preparation of the multiple emulsion and after a certain period of 
time (every seven days), the pH value was measured in triplicate(18) by using a digital 
pH-Meter (CrisonmicropH 2000). All multiple emulsions were measured without any 
previous dilution and at room temperature (25ºC approximately). 
3.2.2.3. Conductivity determination 
The conductivity was measured in order to directly quantify the release of the 
entrapped electrolyte within the internal aqueous phase. All the multiple emulsion 
samples were diluted 1:20 with deionized water under magnetic stirring and were 
measured at 25±1ºC by using a GLP 31 Conductivity meter (Crison Instruments). 
Conductivity measures were performed immediately after the preparation of the 
multiple emulsions and also every seven days in triplicate (18). 
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3.2.2.4. Particle size analysis 
Particle size and distribution analysis of multiple emulsions was performed using a 
Mastersizer S (Malvern Instruments). The instrument combines optic system, dynamic 
light scattering (DLS), with computer support in order to detect particles between 0.02 
and 2000 µm. The results from the analysis were obtained using the derived diameter, 
an internationally agreed method of defining the mean of particle size. 
All measurements were performed at 25ºC and sample particle size values, also known 
as volume-surface mean diameters, were obtained in triplicate and its standard 
deviation was also calculated. 
3.2.2.5. Stability studies 
1. Thermal stability 
The goal of this study is to determinate the thermal stability at different storage 
temperatures through its macroscopic appearance in order to detect its further 
changes over time.  
Identical transparent vials were filled with double emulsion formulations with the 
purpose of observing both surface and general aspect of the different samples through 
time. 
This procedure was performed according to ICH Guidelines (19) and storage 
temperatures were: cold storage (5±1ºC), room temperature (23-26ºC), 30±1ºC, 
40±1ºC and 50±1ºC. Samples were observed every week during the first month and 
afterwards every two weeks.  
2. Physical stability 
A technology based on the analysis of multiple light scattering was used for predicting 
the long-term physical stability of the developed formulations. 
TurbiscanLab® (Formulaction) is used to characterise the stability of concentrated 
emulsions and dispersions. The principle of this measurement is based on using 
infrared light to detect the variation of the droplet volume fraction or mean size such 
as coalescence, flocculation, creaming and sedimentation. 
The main advantage of Turbiscan Lab® is that detects destabilization phenomena up to 
50 times quicker than naked eye, especially in case of opaque and concentrated 
systems (20,21). 
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Samples were not diluted and the test was performed at room temperature   
(23-26ºC) after one month of the double emulsion preparation.  
3.2.2.6. Rheological studies 
Rheological studies are crucial in the characterization of double emulsions; they can 
evaluate its stability (22). 
All measurements of the rotational test were performed by triplicate using a rotational 
rheometer Thermo Scientific HaakeRheostress 1 (Thermo Fischer Scientific) equipped 
with a cone plate set-up with a fixed lower plate and a mobile upper cone Haake 
C60/2º Ti. The device was connected to a temperature control ThermoHaake Phoenix 
II + Haake C25P and to a computer provided with HaakeRheowin® Job Manager 
Software, used to perform the test, and HaakeRheowin® Data Manager, used as data 
analyser. 
The shear rate ramp program included: 
- Ramp-up period: from 0 to 100s-1 in 3min. 
- Constant shear rate period: 100s-1 during 1min. 
- Ramp-down period: from 100 to 0s-1 in 3min. 
The rheological characterization of the samples was performed immediately after the 
preparation and during storage (once every two weeks). All data from the viscosity 
curves (ƞ=(?̇?)) and the flow curves (𝜏=(?̇?)) were recorded at 25ºC including viscosity 
values (Pa·s), apparent thixotropy (Pa/s) and adjusted flow curve-models (23). 
3.2.3. Analysis of drug content in the double emulsion 
3.2.3.1. Preparation of standard solutions for the calibration curve 
The analytical method for the analysis of drug content has been previously validated; 
therefore, the linearity of the analytical procedure has been tested once determining 
the calibration curve.  
With the purpose of preparing the phosphate solution, 8.709 g of K2HPO4 was diluted 
in 1 L of H2O Milli Q. Consecutively; the dilution was sonicated in an ultrasound bath 
for 10 minutes. Once the phosphate solution was ready, the vehicle was prepared by 
adding 250 mL of phosphate solution to 750 mL of methanol. Finally, a swept-
wavelength was performed in order to determinate in which wavelength Bifonazole 
had its peak. 
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On the other hand, standard stock solutions of Bifonazole were prepared by diluting 20 
mg of drug in 10 mL of vehicle (methanol/phosphate solution 75:25). The final 
concentration obtained was 2.0 mg/mL. From these standard solution stocks of 10, 8, 
6.4, 5.1, 4.08, 3.26 and 2.61 µg/mL were prepared with the same solvent. 
 
 
Figure 5: Standard solutions preparation 
3.2.3.2. Preparation of double emulsion solutions 
With the aim of analysing the Bifonazole content, all double emulsion samples were 
broken using the following procedure:  
1. 500mg of double emulsion sample was diluted in 5 mL of methanol. 
2. The dilution was sonicated in an ultrasound bath for 10 minutes. 
3. The dilution was homogenised by centrifugation at 3000 rpm during 10 
minutes. 
4. The resulting supernatant was transferred to vial A. 
5. 0.5 mL of vial A supernatant was diluted in 5mL of methanol in vial B. 
6. 0.5mL of dilution of vial B was also diluted in 5mL of methanol/phosphate 
solution (75:25) in vial C. 
7. The resulting solution in vial C was filtered and tested spectrophotometrically. 
The spectrums of all the resulting solution were recorded twice using the 
methanol/phosphate solution (75:25) as blank.  
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4. RESULTS AND DISCUSSION 
4.1. CHARACTERIZATION OF DOUBLE EMULSIONS 
The multiple emulsion components are of significant importance to ensure the stability 
and release properties desired. 
4.1.1. Organoleptic characteristics 
All the multiple emulsion samples show strong similarities in their appearance. All 
water-in-oil-in-water emulsions are homogeneous, fluid, bright and white to pearly 
creams.  
4.1.2. Microscopic analysis 
Multiple emulsions microscopic structure can be observed in all samples (Figures from 
6 to 10), therefore, small water droplets are dispersed in oil and those are dispersed as 
large droplets inside an aqueous continuous phase.  
Figure 6: JMIM01B microscopic image Figure 7: JMIM01BT microscopic image 
 
Figure 8: JMSA01B microscopic image 
 
Figure 9: JMSA01BT microscopic image 
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Figure 10: JMYB01BT microscopic image 
Significant variations cannot be observed in photomicrographs above (figures 6 to 10). 
All samples show similar droplet size. These results are in accordance to the ones 
obtained from the Mastersizer analysis. 
Finally, it could be affirmed that the multiplicity is maintained through storage time. 
Hence, all the multiple emulsions formulations are stable over time in its microscopic 
structure.  
4.1.3. pH determination 
After performing pH measurements during 10 weeks, figure 11 shows pH values 
evolution over storage time for multiple emulsion samples with different oil phase 
composition. 
 
Figure 11: pH measurements as function of storage time 
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As we can see, all multiple emulsions have a pH between 5.8 and 7.3. According to the 
suitable pH for topical administration, which has been reported to be between 5.4 and 
5.9 (24), only one sample would be accepted as a topical cream, the multiple emulsion 
formulated with Isopropyl Myristate which has been prepared using the Ultra-Turrax 
(JMIM01BT). The rest of the samples would have unreasonable basic pH for topical 
application. 
Finally, it can be observed that all samples show constant pH values which could be a 
sign of stability through time.  
4.1.4. Conductivity determination 
After performing conductivity measurements for 10 weeks, figure 12 shows 
conductivity (µs/cm) evolution over time (days) for double emulsions with different oil 
phase composition. 
 
Figure 12: Conductivity values as function of storage time 
Observing the graphic of the sample formulated with sweet almonds oil without Ultra-
Turrax procedure (JMSA01B), it can be ensured that such a drastically decrease of 
conductivity over time means that it is an instable formulation, therefore, sweet 
almonds oil would not be a good candidate in the formulation of a water-in-oil-in-
water emulsion of Bifonazole. 
According to the rest of the samples, all the double emulsion formulation maintains its 
conductivity through time, a fact that could be interpreted as a sing of stability. 
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In case of Isopropyl Myristate formulation without Ultra-turrax procedure (JMIM01B) it 
can be seen a slight increase of conductivity. It could have been a phenomenon of 
water and NaCl migration from the inner water phase to the outer water phase (25). 
4.1.5. Particle size analysis 
After the droplet size analysis performed by Mastersizer S, important differences 
between formulations in reference to particle size distribution can be observed. While 
samples formulated with Isopropyl Myristate without Ultra-Turrax procedure 
(JMIM01B) (figure 13) and with Jojoba Oil (JMYB01BT) (figure 14) only have one size 
population, in the rest of the samples two size populations could be found (figure 15 to 
17). 
 
 
Figure 13: JMIM01B particle size distribution 
 
 
 
Figure 14: JMYB01BT particle size distribution 
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Figure 15: JMIM01BT particle size distribution 
 
 
 
Figure 16: JMSA01B particle size distribution 
 
 
 
Figure 17: JMSA01BT particle size distribution 
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In addition to the droplet size distribution, it is worth analysing the droplet size of 
each formulation. Table 5 includes the particle size (volume-surface mean diameters) 
of all the multiple emulsions.**Faltacomentari sobre particle size table 5 quantingui 
els resultats** 
 
ParticleSize (µm) 
JMIM01B  
JMIM01BT  
JMYB01BT  
JMSA01B  
JMSA01BT  
Table 5: Particle size values 
In conclusion, several differences between samples can be highlighted in reference to 
droplet size distribution but regarding particle size analysis any important 
discrepancy can be emphasise.   
4.1.6. Stability studies 
For the selection of optimal multiple emulsions formulations, stability studies were 
performed in order to investigate the effect of storage. 
4.1.6.1. Thermal stability 
In order to simplify data analysis, a schematic stability table (table 6) was prepared 
with two colours (green for stable samples and red for instable ones) and with the 
following abbreviations: 
- Stable (S): Unaltered sample. Its macroscopic appearance remains unchanged 
over time. 
- Burned (B): Due to the density difference between the internal and the external 
phase, the sample has changed its appearance and two different phases can be 
observed. 
- Exude (E): The sample is starting the emulsion-breaking process. Some oil 
droplets can be observed on the surface. 
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  STABILITY 
DAYS Cold store RoomTª 30ºC 40ºC 50ºC 
JM
IM
0
1
B
 
1 S S S S S 
7 S S S S B 
15 S S S S B 
22 S S S B B 
30 S S S B B 
45 S S S B B 
75 S S S B B 
  
JM
IM
0
1
B
T
 
1 S S S S S 
7 S S S S S 
15 S S S S B 
22 S S S B B 
30 S S S B B 
45 S S S B B 
75 S S S B B 
  
JM
Y
B
0
1
B
T 
1 S S S S S 
7 S S S S S 
15 S S S S B 
22 S S S S B 
30 S S S S B 
45 S S S S B 
75 S S S S B 
 
JM
SA
0
1
B
 
1 S S S S S 
7 S S S S B 
15 S S S S B 
22 S S S S B 
30 S S S B B 
45 S S S B B 
75 S S S B B 
  
JM
SA
0
1
B
T 
1 S S S S S 
7 S S S S B 
15 S S S S B 
22 S S S S B 
30 S S S S B 
45 S S S B B 
75 S S S B B 
Table 6:Thermal stability 
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The data shown in the table above (Table 6) evince the different behaviour of the 
samples depending on its oil phase formulation. Exclusively the sample formulated 
with Jojoba oil (JMYB01BT) could have been storage during 10 weeks at 40ºC without 
destabilising (Figure 18). 
 
Figure 18: JMYB01BT samples 
In conclusion, the results confirm that all samples can be storage during 10 weeks 
under cold and room temperatures and even at 30ºC and remain stables. 
4.1.6.2. Physical stability 
Figures 19 to 23 show multiple emulsions physical stability after performing Turbiscan 
Lab® analysis. No signals on the variation of the droplet volume fraction (migration) or 
mean size (coalescence) has been observed during 24 hours on all the multiple 
emulsions formulations. As a consequence, no significantly particle size variation 
(%ΔBS, <10%) phenomenon occurred over the analysed period.  
 
 
Figure 19: JMIM01B physical stability 
 
5ºC    Room Tª   30ºC     40ºC   50ºC 
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Figure 20: JMIM01BT physical stability 
 
 
 
Figure 21:JMYB01BT physical stability 
 
 
 
Figure 22: JMSA01B physical stability 
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Figure 23: JMSA01BT physical stability 
 
4.1.6.3. Rheological studies 
Rheological data analysis was performed using HaakeRheowin® Data Manager. 
Viscosity mean values (Pa·s) from all samples were determined from the constant 
share section at 100s-1 (Figure 24). 
 
Figure 24: Viscosity mean values in function of time storage 
As shown in Figure 24, viscosity evolution over storage time differs between multiple 
emulsions formulations. While samples JMIM01B, JMYB01BT and JMSA01B maintain 
its viscosity through time, the other two samples suffer a significant decrease over 
time. Thus could be due to the destabilization of the sample or the inner multiple 
emulsion properties which tend to destabilization. 
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Therefore, it can be assured that the best sample referring to viscosity determination 
is the one formulated with Jojoba oil (JMYB01BT). It perfectly maintains its high initial 
viscosity through time. 
In reference to the determination of the apparent thixotropic (Pa/s), it was evaluated 
by determining the hysteresis loop area which can be described as the area between 
ramp-up and ramp-down periods (Figures 25 to 29). 
 
 
Figure 25: JMIM01B rheological study 
 
 
 
Figure 26: JMIM01BT rheological study 
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Figure 27: JMYB01BT rheological study 
 
 
 
 
 
 
Figure 28: JMSA01B rheological study 
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Figure 29: JMSA01B rheological study 
As shown in pictures 25 to 29 all multiple emulsion samples present different 
hysteresis loop area which lead to show discrepancies in apparent thixotropic (Pa/s). 
None of those discrepancies are significant because are exclusively caused by different 
oil phase of the multiple emulsions formulations. 
Finally, HaakeRheowin® Data Manager adjusted the data from the flow curve (𝜏=(?̇?)) to 
different mathematical models (Table 7) in order to determinate which model adjusted 
better to each sample. 
 
Table 7: Flow-curve models (26) 
Table 8 includes the rheological behaviour analysis of all double emulsions samples at 
all times. It reveals that all formulations have a pseudoplastic behaviour fitted by Cross 
model with a good correlation coefficient (r).  
As example, Figure 30 show how Cross flow-curve (green line) suits perfectly to 
JMIM01B sample behaviour. 
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Figure 30: JMIM01B Cross flow-curve 
  
TIME 
(Days) 
BETTER MATHEMATICAL MODEL FITTING RHEOLOGICAL 
BEHAVIOUR Ramp-up section Ramp-down section 
JM
IM
0
1
B
 
0 r = 0,9997 Cross r = 0,9998 Cross Pseudoplastic 
15 r = 0,9994 Cross r = 0,9999 Cross Pseudoplastic 
30 r = 0,9989 Cross r = 0,9999 Cross Pseudoplastic 
45 r = 0,9991 Cross r = 0,9998 Cross Pseudoplastic 
60 r = 0,9990 Cross r = 0,9999 Cross Pseudoplastic 
JM
IM
0
1
B
T 
0 r = 0,9860 Cross r = 0,9999 Cross Pseudoplastic 
15 r = 0,9692 Cross r = 0,9999 Cross Pseudoplastic 
30 r = 0,9854 Cross r = 0,9999 Cross Pseudoplastic 
45 r = 0,9979 Cross r = 0,9999 Cross Pseudoplastic 
60 r = 0,9985 Cross r = 0,9999 Cross Pseudoplastic 
JM
YB
0
1
B
T 
0 r = 0,9976 Cross r = 0,9997 Cross Pseudoplastic 
15 r = 0,9890 Cross r = 0,9998 Cross Pseudoplastic 
30 r = 0,9885 Cross r = 0,9998 Cross Pseudoplastic 
45 r = 0,9809 Cross r = 0,9999 Cross Pseudoplastic 
60 r = 0,9871 Cross r = 0,9999 Cross Pseudoplastic 
JM
SA
0
1
B
 
0 r = 0,9999 Cross r = 1 Cross Pseudoplastic 
15 r = 0,9989 Cross r= 0,9999 Cross Pseudoplastic 
30 r = 0,9996 Cross r = 0,9999 Cross Pseudoplastic 
45 r = 0,9990 Cross r = 0,9999 Cross Pseudoplastic 
60 r = 0,9990 Cross r = 0,9999 Cross Pseudoplastic 
JM
SA
0
1
B
T 
0 r = 0,9990 Cross r = 0,9995 Cross Pseudoplastic 
15 r = 0,9973 Cross r = 0,9997 Cross Pseudoplastic 
30 r = 0,9943 Cross r = 0,9997 Cross Pseudoplastic 
45 r = 0,9918 Cross r = 0,9997 Cross Pseudoplastic 
60 r = 0,9951 Cross r = 0,9997 Cross Pseudoplastic 
Table 8: Better mathematical model fitting 
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4.2. DRUG CONTENT 
Firstly, the calibration curve was obtained (Figure 31) with the absorbance over the 
concentration results of the different standard solutions. 
 
Figure 31: Calibration curve 
Afterwards, the drug content analysis was performed and the results are shown in 
table 9. 
  Absorbance Concentration (µg/ml) Drug Content (%) 
JMIM01B 0,7175 0,964 96,4% 
JMIM01BT 0,7465 1,004 100,4% 
JMYB01BT 0,7740 1,041 104,1% 
JMSA01B 0,6790 0,912 91,2% 
JMSA01BT 0,7265 0,977 97,7% 
Table 9: Bifonazole content 
These values reveal that the experimental amounts extracted from the formula are 
very close to the theoretical ones which are 100% of Bifonazole. Therefore, the drug 
content of all different samples is indeed acceptable. 
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5. CONCLUSIONS 
The study of the formulation and characterization of different multiple emulsions with 
1% Bifonazole is contained in the present work. It describes the preparation of five 
formulations that differ only in the oil phase and in the Ultra-Turrax method 
preparation. The following conclusions may be drawn from this study: 
1. In reference to organoleptic characteristics, all multiple emulsions had similar 
appearance in homogeneity, fluidity, brightly and white to pearly creams. 
2. In all cases water-in-oil-in-water structure was confirmed by microscopic 
analysis which showed non-significant differences between samples that were 
prepared with our without the Ultra-Turrax method. 
3. Concerning the pH analysis, only the sample JMIM01BT had suitable pH for 
topical administration. 
4. Furthermore, conductivity analysis did not show relevant differences between 
samples, except JMSA01B that has dramatically decreased after 30 days. 
5. Particle size analysis Esperar a resultats de Mastersizer. 
6. Regarding the stability studies it could be deduced that all the formulations are 
stable thermal and physically through storage time. 
7. All rheological analysis reveals the good stability of the multiple emulsions 
formulations. Besides, it might be assured that the best viscosity stability 
through time is provided by the sample formulated with Jojoba oil (JMYB01BT). 
8. In reference to drug content, all the samples are between the limits of drug 
content acceptance according to ICH (90-110%). 
In conclusion, as it can be deduced from the characterization tests, the optimal 
multiple emulsion is the one formulated with Jojoba oil (JMYB01BT). Once it has 
been demonstrated which is the optimal oil phase for the multiple emulsion 
stability, the following step would be to perform biopharmaceutical studies in 
order to provide sustaining data about Bifonazole releasing properties.  
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